Activation with PMA/Ion revealed an augmented level of pro-inflammatory cytokine release from CD4+ T cells of T2DM patients when compared with healthy controls, including TNF-α, GM-CSF, IFN-γ, and IL-17 (Figures 3A, B). This evidence concerns the gene IL17A and type 2 diabetes mellitus.